Safoora Naaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Safoora Naaz has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Biju Viswanath
National Institute of Mental Health and Neuro Sciences
3 shared publications - Meera Purushottam
Department of Psychiatry National Institute of Mental Health and Neurosciences Bangalore India
3 shared publications - Reeteka Sud
Department of Psychiatry National Institute of Mental Health and Neurosciences Bangalore India
2 shared publications - Srinivas Balachander
OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
2 shared publications - Y. C. Janardhan Reddy
OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
2 shared publications - Aparna Ashok
National Institute of Mental Health and Neurosciences, Bangalore, India
1 shared publication
Latest Publications
- Open Access
Cell cycle abnormality is a cellular phenotype in OCD
Abnormal indices of cell cycle regulation have been reported in multiple psychiatric disorders. Though reports specific to obsessive compulsive disorder (OCD) are scant, numerous studies have highlighted partly common underlying biology in psychiatric disorders, cell cycle regulation being one such process. In this study, we therefore aimed to explore cell cycle in OCD. To the best of our knowledge, this is the first study to investigate these effects in OCD. We also evaluated the effect of in vitro fluoxetine, commonly used serotonin reuptake inhibitor (SRI) in OCD patients, on cell cycle regulation. The effects of both disease (OCD) and treatment (SRI) were assessed using lymphoblastoid cell lines (LCLs), derived from OCD patients and healthy controls, as a model system. LCLs were treated with 10μM of fluoxetine for 24 hours, and the percentage of cells in each phase of the cell cycle was determined by flow cytometry. We observed a lower proportion of cells in the G2/M phase in OCD cases than controls. The findings suggest that cell cycle dysregulation could be peripheral cellular phenotype for OCD. Among cases, all of whom had been systematically characterized for SRI treatment response, LCLs from non-responders to SRI treatment had a lower proportion of cells in G2/M phase than responders.
Open AccessCell cycle abnormality is a cellular phenotype in OCD
Abnormal indices of cell cycle regulation have been reported in multiple psychiatric disorders. Though reports specific to obsessive compulsive disorder (OCD) are scant, numerous studies have highlighted partly common underlying biology in psychiatric disorders, cell cycle regulation being one such process. In this study, we therefore aimed to explore cell cycle in OCD. To the best of our knowledge, this is the first study to investigate these effects in OCD. We also evaluated the effect of in vitro fluoxetine, commonly used serotonin reuptake inhibitor (SRI) in OCD patients, on cell cycle regulation. The effects of both disease (OCD) and treatment (SRI) were assessed using lymphoblastoid cell lines (LCLs), derived from OCD patients and healthy controls, as a model system. LCLs were treated with 10μM of fluoxetine for 24 hours, and the percentage of cells in each phase of the cell cycle was determined by flow cytometry. We observed a lower proportion of cells in the G2/M phase in OCD cases than controls. The findings suggest that cell cycle dysregulation could be peripheral cellular phenotype for OCD. Among cases, all of whom had been systematically characterized for SRI treatment response, LCLs from non-responders to SRI treatment had a lower proportion of cells in G2/M phase than responders.
- Open Access
Association of SAPAP3 allelic variants with symptom dimensions and pharmacological treatment response in obsessive-compulsive disorder
Background: Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. Methods: A total of 200 subjects with OCD were genotyped using the TaqMan assay. All subjects were assessed using Mini International Neuropsychiatric Interview, the Yale-Brown Obsessive-Compulsive Scale, and their treatment response was evaluated over naturalistic treatment and follow-up. Results: After correcting for multiple comparisons, G-allele at rs6662980 was found to be associated with contamination/washing symptoms (p=0.003). Logistic regression analysis also showed that presence of G allele predicted poor response to serotonin reuptake inhibitors [odds ratio = 2.473 (95% CI = 1.157 - 5.407), p=0.021]. Interaction between presence of G-allele and contamination factor score predicted SRI resistance (B= 1.197, p = 0.006). Limitations: We did not use a dimensional measure for assessing OCD symptoms. Treatment response was assessed over naturalistic follow-up. Conclusion: Specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to serotonin reuptake inhibitors, may be related to alterations in the SAPAP3 gene. Public Significance Statement: “This study finds that a specific polymorphism in the SAPAP3 gene, was found to be associated with the contamination/washing symptoms of OCD and was also found to predict resistance to pharmacological treatment” Highlights: SAPAP3 gene is implicated in OCD Association of SAPAP3 gene (rs6662980) with OCD phenotypes was examined Presence of the minor (G) allele predicted contamination & washing symptoms SAPAP3 polymorphism had a significant association with treatment response Interaction between presence of G-allele and contamination factor score predicted treatment resistance
Open AccessAssociation of SAPAP3 allelic variants with symptom dimensions and pharmacological treatment response in obsessive-compulsive disorder
Background: Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. Methods: A total of 200 subjects with OCD were genotyped using the TaqMan assay. All subjects were assessed using Mini International Neuropsychiatric Interview, the Yale-Brown Obsessive-Compulsive Scale, and their treatment response was evaluated over naturalistic treatment and follow-up. Results: After correcting for multiple comparisons, G-allele at rs6662980 was found to be associated with contamination/washing symptoms (p=0.003). Logistic regression analysis also showed that presence of G allele predicted poor response to serotonin reuptake inhibitors [odds ratio = 2.473 (95% CI = 1.157 - 5.407), p=0.021]. Interaction between presence of G-allele and contamination factor score predicted SRI resistance (B= 1.197, p = 0.006). Limitations: We did not use a dimensional measure for assessing OCD symptoms. Treatment response was assessed over naturalistic follow-up. Conclusion: Specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to serotonin reuptake inhibitors, may be related to alterations in the SAPAP3 gene. Public Significance Statement: “This study finds that a specific polymorphism in the SAPAP3 gene, was found to be associated with the contamination/washing symptoms of OCD and was also found to predict resistance to pharmacological treatment” Highlights: SAPAP3 gene is implicated in OCD Association of SAPAP3 gene (rs6662980) with OCD phenotypes was examined Presence of the minor (G) allele predicted contamination & washing symptoms SAPAP3 polymorphism had a significant association with treatment response Interaction between presence of G-allele and contamination factor score predicted treatment resistance
- 1 January 2019
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 39, 174-177
Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes?
- 1 January 2019
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 39, 174-177
Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes?